Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea (Ebola-Tx)
Sponsor: Aix Marseille Université
Listed as NCT02342171, this PHASE2/PHASE3 trial focuses on Hemorrhagic Fever, Ebola and remains completed. Sponsored by Aix Marseille Université, it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE2_PHASE3
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 4 earlier versions
-
Nov 2018 — Aug 2019 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Completed PHASE2_PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Mar 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aix Marseille Université
- Belgian Red Cross
- Etablissement Français du Sang
- Gamal Abdel Nasser University of Conakry
- Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
- Institut National de la Santé Et de la Recherche Médicale, France
- Institut Pasteur, Dakar, Sénégal
- Institute of Tropical Medicine, Belgium
- International Severe Acute Respiratory and Emerging Infection Consortium
- London School of Hygiene and Tropical Medicine
- Médecins Sans Frontières, Belgium
- National Blood Transfusion Centre (NBTC), Conakry, Guinea
- National Center for Training and Research of Maferinyah, Guinea
- UBIVE, Institut Pasteur, Paris, France
- University of Liverpool
- University of Oxford
- World Health Organization
For direct contact, visit the study record on ClinicalTrials.gov .